CoChat
Sign Up
Cited by 14Radiation Therapy and DosimetryEffects of Radiation ExposureAdvanced Radiotherapy Techniques

The DOI matches its Crossref record.

Assessment of cancer risk from neutron exposure – The ANDANTE project

Ottolenghi, A., Smyth, V., Trott, K.R.·2013·Radiation Measurements
DOI 10.1016/j.radmeas.2012.10.017
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/j.radmeas.2012.10.017

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Established radiation protection standards depend on the dataset adopted for the evaluation.

    “The established radiation protection standards therefore depend on the dataset adopted for the evaluation8.”

    From The origin of neutron biological effectiveness as a function of energy (2016) · cites this paper as [8]

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 28

  1. Alloni, 2011, Monte Carlo evaluation of DNA fragmentation spectra induced by different radiation qualities, Radiat. Prot. Dosim., 143, 226, 10.1093/rpd/ncq384 · DOI
  2. Alloni, 2012, Track structure, radiation quality and initial radiobiological events: considerations based on the PARTRAC code experience, Int. J. Radiat. Biol., 88, 77, 10.3109/09553002.2011.627976 · DOI · Paper page
  3. Athar, 2009, Neutron equivalent doses and associated lifetime cancer incidence risks for head & neck and spinal proton therapy, Phys. Med. Biol., 54, 4907, 10.1088/0031-9155/54/16/005 · DOI
  4. Barendsen, 1966, The effect of oxygen on impairment of the proliferative capacity of human cells in culture by ionising radiations of different LET, Int.J.Radiat.Biol., 10, 317, 10.1080/09553006614550421 · DOI
  5. Belli, 2010, The European strategy on low dose risk research and the role of radiation quality according to the Recommendations of the "ad hoc" High Level and Expert Group (HLEG.), Radiat. Environ. Biophys., 49, 463, 10.1007/s00411-010-0284-2 · DOI
  6. Breitkreutz, 2008, Spectral fluence rates of the fast reactor neutron beam MEDAPP at FRM II, Nucl. Instrum. Methods Phys. Res. A, 593, 466, 10.1016/j.nima.2008.05.008 · DOI
  7. Campa, 2005, DNA DSB induced in human cells by charged particles and gamma rays: experimental results and theoretical approaches, Int. J. Radiat. Biol., 81, 841, 10.1080/09553000500530888 · DOI
  8. Constine, 2008, Subsequent malignancies in children treate for Hodgkin’s disease: associations with gender and radiation dose, Int.J.Radiat.Oncol.Biol. Phys., 72, 24, 10.1016/j.ijrobp.2008.04.067 · DOI
  9. De Vathaire, 1999, Second malignant neoplasms after a first cancer in childhood. Temporal pattern of risk according to type of treatment, Br.J.Cancer, 79, 1884, 10.1038/sj.bjc.6690300 · DOI
  10. Diallo, 2009, Frequency distribution of second solid cancer locations in relation to the irradiated volume among 115 patients treated for childhood cancer, Int.J.Radiat.Oncol.Biol.Phys., 74, 876, 10.1016/j.ijrobp.2009.01.040 · DOI
  11. Fontenot, 2010, Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy, Phys. Med. Biol., 55, 6987, 10.1088/0031-9155/55/23/S02 · DOI
  12. Hooning, 2006, Cause-specific mortality in long-term survivors of breast cancer: a 25-year follow-up study, Int. J. Radiat. Oncol. Biol. Phys., 64, 1081, 10.1016/j.ijrobp.2005.10.022 · DOI
  13. ICRP Publication 103, 2007, The 2007 Recommendations of the international commission on radiological protection, Ann. ICRP, 37
  14. ICRP Publication 92, 2003, Relative Biological Effectiveness (RBE), QualityFactor (Q), and Radiation Weighting Factor (wR), Ann. ICRP, 33
  15. Kase, 2008, Biophysical calculation of cell survival probabilities using amorphous track structure models for heavy-ion irradiation, Phys. Med. Biol., 53, 37, 10.1088/0031-9155/53/1/003 · DOI
  16. Kellerer, 2006, Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors, Health Phys. Jun., 90, 554, 10.1097/01.HP.0000184917.94232.cd · DOI
  17. Neglia, 2001, Second malignant neoplasms in five-year survivors of childhood cancer: childhood Cancer Survivor Study, J.Natl. Cancer Inst., 93, 619, 10.1093/jnci/93.8.618 · DOI
  18. Newhauser, 2009, The risk of developing a second cancer after receiving craniospinal proton irradiation, Phys. Med. Biol., 54, 2277, 10.1088/0031-9155/54/8/002 · DOI
  19. Ottolenghi, 2011, The risks to healthy tissues from the use of existing and emerging techniques for radiation therapy, Radiat. Prot. Dosimetry., 143, 533, 10.1093/rpd/ncq524 · DOI
  20. Rosenfeld, 2002, Solid state microdosimetry in hadron therapy, Radiat. Prot. Dosim., 101, 431, 10.1093/oxfordjournals.rpd.a006019 · DOI
  21. Rosenfeld, 2006, Method of Monte Carlo simulation verification in hadron therapy with non-tissue equivalent detectors, Radiat. Prot. Dosim., 119, 487, 10.1093/rpd/nci618 · DOI
  22. Schmid, 2009, Dose response relationship of dicentric chromosomes in human lymphocytes obtained for the fission neutron therapy facility MEDAPP at the research reactor FRM II, Radiat. Environ. Biophys., 48, 67, 10.1007/s00411-008-0202-z · DOI
  23. Scholz, 1996, Track structure and the calculation of biological effects of heavy charged particles, Adv. Space Res., 18, 5, 10.1016/0273-1177(95)00784-C · DOI
  24. Turkenova, 2011, Radiation Therapy and late mortality from second sarcoma, carcinoma, and haematological malignancies after solid cancer in childhood, Int.J.Raiat.Oncol.Biol. Phys., 80, 339, 10.1016/j.ijrobp.2010.02.004 · DOI
  25. Withers, 1982, Biological bases for high RBE values for late effects of neutron irradiation, Int.J.Radiat.Oncol.Biol. Phys., 8, 2026, 10.1016/0360-3016(82)90547-8 · DOI
  26. Wroe, 2007, Out-of-field dose equivalents delivered by proton therapy of prostate cancer, Med. Phys., 34, 3449, 10.1118/1.2759839 · DOI
  27. Wroe, 2009, Out-of-field dose equivalents delivered by passively scattered therapeutic proton beams for clinically relevant field configurations, Int. J. Radiat. Oncol. Biol. Phys., 73, 306, 10.1016/j.ijrobp.2008.09.030 · DOI
  28. Zhang, 2010, An analytic model of neutron ambient dose equivalent and equivalent dose for proton radiotherapy, Phys. Med. Biol., 55, 6975, 10.1088/0031-9155/55/23/S01 · DOI

Cited by

Sorted by citations

Metadata

Authors
Ottolenghi, A., Smyth, V., & Trott, K. R.
Affiliations
University of Pavia (IT)
Corresponding author
Smyth, V.
ORCID
Ottolenghi, A.
Venue
Radiation Measurements
Publisher
Elsevier BV
Published
2013-10
Volume
57
Pages
68-73
ISSN
1350-4487 (ISSN-L)
DOI
10.1016/j.radmeas.2012.10.017
OpenAlex
W2100966877
Cited by
14
References
0
Citations by year
2026: 1 · 2025: 1 · 2023: 1 · 2021: 1 · 2020: 4 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 3
FWCI
0.75
Type
journal article
Language
en
Open access
closed
Locations
Radiation Measurements (publishedVersion)
Topics
  • Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
  • Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
Keywords
relative biological effectiveness, secondary malignancies, pediatric radiotherapy, salivary gland carcinoma, thyroid cancer, breast cancer, track structure model, neutron fluence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review